In addition, EGFR inhibitors have themselves been shown to exert antiangiogenic effects by reducing the expression of VEGF and other angiogenic factors by tumours (Ciardiello et al, 2001), and inhibiting EGFR on tumour endothelium (Bruns et al, 2000; Baker et al, 2002). Here, EGFR is linked to neoplasm.